Product NDC: | 0003-2327 |
Proprietary Name: | YERVOY |
Non Proprietary Name: | ipilimumab |
Active Ingredient(s): | 5 mg/mL & nbsp; ipilimumab |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0003-2327 |
Labeler Name: | E.R. Squibb & Sons, L.L.C. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125377 |
Marketing Category: | BLA |
Start Marketing Date: | 20110325 |
Package NDC: | 0003-2327-11 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0003-2327-11) > 50 mL in 1 VIAL, SINGLE-USE |
NDC Code | 0003-2327-11 |
Proprietary Name | YERVOY |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0003-2327-11) > 50 mL in 1 VIAL, SINGLE-USE |
Product NDC | 0003-2327 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ipilimumab |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110325 |
Marketing Category Name | BLA |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | IPILIMUMAB |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes |